Ozurdex is a new injectable drug delivery system for the eye. Over the past few months we've talked about new technology and the emergence of several sustained release drug delivery systems. About 2 weeks ago, I injected the left eye of one of my patients with Ozurdex™. Ozurdex will release a steroid, dexamethasone, for up to 6 months. The FDA approved Ozurdex for the treatment of … [Read more...]
Ozurdex Implant Likely to Help Diabetic Macular Edema
September 8, 2009 By
There is a new implant available to us in the United States for treatment of macular swelling (edema). The implant, Ozurdex®, is a product of Allergan Pharmaceuticals and received FDA approval in June 2009 for treatment of macular edema caused by retinal vascular occlusions. Ozurdex® is now available for your doctor to use when indicated. What does Ozurdex have to do with diabetic … [Read more...]
Steroid Implant May Reduce Diabetic Retinal Edema
July 21, 2009 By Leave a Comment
In June, the FDA approved a new intraocular device for the treatment of so-called retinal vein occlusions. In this disease, the whole or partial venous tree of the retina becomes occluded. Secondary swelling of the macula occurs thereby reducing vision. Current therapy involves only laser treatment. This new drug delivery system, marketed by Allergan Pharmaceuticals, will be available later … [Read more...]
